Edesa Biotech, Inc. (EDSA) vs Elicio Therapeutics, Inc. (ELTX)

A side-by-side comparison of Edesa Biotech, Inc. and Elicio Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Edesa Biotech, Inc. logo
EDSA
Edesa Biotech, Inc.
$37M
$3.84HealthcareDelayed quote: Oct 6, 2026, 11:18 AM EDT
Elicio Therapeutics, Inc. logo
ELTX
Elicio Therapeutics, Inc.
$37M
$1.94HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT

Total return — EDSA vs ELTX

growth of $100 · dividends reinvested · last 3y
EDSA +24.9% (+7.7%/yr)ELTX -67.4% (-31.2%/yr)EDSA compounded faster over this window
0200400600Start $100202420252026$125$33
EDSA ELTX

EDSA vs ELTX: by the numbers

  • •EDSA is the larger company ($37M vs $37M market cap).

Metrics side by side

Valuation

MetricEDSAELTX
P/B ratio92.714.66

Profitability

MetricEDSAELTX
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-160.05%-476.77%
ROIC-166.02%-171.36%

Growth (annualized)

MetricEDSAELTX
Total return CAGR (5Y)-39.88%N/A

Go deeper

Full EDSA analysisFull ELTX analysisInteractive comparison tool

Dig into the metrics

Edesa Biotech ROEElicio Therapeutics ROEEdesa Biotech operating marginElicio Therapeutics operating marginEdesa Biotech revenue growthElicio Therapeutics revenue growthEdesa Biotech free cash flowElicio Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.